Tellgen Life
SZSE · 300642
Market Cap$2.1B
Revenue$371.5M
Listed OnSZSE
Ticker300642
CEO / ExecMr. Jian Er Yao
HeadquartersShanghai
MarketMainland China
Websitewww.tellgen.com
Overview
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.